Unveiling the Hidden Culprit: Subcutaneous Inguinal Phosphaturic Mesenchymal Tumour Causing Tumour-Induced Osteomalacia
Indian Journal of Nuclear Medicine · 10.06.2026 · 41 · 379-381
DOI: 10.25259/ijnm_186_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Nuclear Medicine, online erschienen am 10.06.2026. Verfasst von Jaswinder Kaur und 4 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Tumour-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by excess fibroblast growth factor-23 (FGF23), leading to renal phosphate wasting and hypophosphatemia. Patients present with nonspecific bone pain, muscle weakness, and fractures, resulting in significant diagnostic delays. Benign phosphaturic mesenchymal tumours are causative and are commonly located in the bones and soft tissues of the lower limbs and the head and neck. Complete surgical excision is curative, emphasising the need for lesion localisation. We present a rare case of a subcutaneously located lesion in the uncommonly reported inguinal region. Functional imaging utilising 68 Ga-DOTANOC PET/CT offers unparalleled detection rates in this pathology.
Zitieren
APA
Kaur, J., Sharma, S., Jagannath, S., Mayilvaganan, S., & Ora, M. (2026). Unveiling the Hidden Culprit: Subcutaneous Inguinal Phosphaturic Mesenchymal Tumour Causing Tumour-Induced Osteomalacia. Indian Journal of Nuclear Medicine, 41, 379-381. https://doi.org/10.25259/ijnm_186_25
Vancouver
Kaur J, Sharma S, Jagannath S, Mayilvaganan S, Ora M. Unveiling the Hidden Culprit: Subcutaneous Inguinal Phosphaturic Mesenchymal Tumour Causing Tumour-Induced Osteomalacia. Indian Journal of Nuclear Medicine. 2026;41:379-381. doi:10.25259/ijnm_186_25
BibTeX
@article{Kaur2026,
author = {Kaur, Jaswinder and Sharma, Siddharth and Jagannath, Spandana and Mayilvaganan, Sabaretnam and Ora, Manish},
title = {Unveiling the Hidden Culprit: Subcutaneous Inguinal Phosphaturic Mesenchymal Tumour Causing Tumour-Induced Osteomalacia},
journal = {Indian Journal of Nuclear Medicine},
year = {2026},
volume = {41},
pages = {379--381},
doi = {10.25259/ijnm_186_25}
}
EUVIMED